DNA damage can cause mutations that contribute to cellular transformation and tumorigenesis. The p53 tumor suppressor acts to protect the organism from DNA damage by inducing either G1 arrest to facilitate DNA repair or by activating physiological cell death (apoptosis). Consistent with this critical function of p53, mice lacking p53 are predisposed to developing tumors, particularly lymphoma. The severe combined immune deficiency (scid~ locus encodes the catalytic subunit of DNA protein kinase (DNA-PKcs), a protein complex that has a role in the cellular response to DNA damage. Cells from scid mice are hypersensitive to radiation and scid lymphocytes fail to develop from precursors because they are unable to properly join DNA-coding ends during antigen receptor gene rearrangement. We examined the combined effect of loss of p53 and loss of DNA-PKcs on lymphocyte development and tumorigenesis by generating p53 -/-scid mice. Our data demonstrate that loss of p53 promotes T-ceU development in scid mice but does not noticeably affect B lymphopoiesis. Moreover, scid cells are able to induce p53 protein expression and activate G1 arrest or apoptosis in response to ionizing radiation, indicating that DNA-PKcs is not essential for these responses to DNA damage. Furthermore, p53 -/-scid double mutant mice develop lymphoma earlier than p53 -/-littermates, demonstrating that loss of these two genes can cooperate in tumorigenesis. Collectively, these results provide evidence for an unsuspected role of p53 as a checkpoint regulator in early T-cell development and demonstrate that loss of an additional component of the cellular response to DNA damage can cooperate with loss of p53 in lymphomagenesis.
ation (Fulop and Phillips 1990; Biedermann et al. 1991) . Recently, the scid gene product was identified as p450, the catalytic subunit of the DNA-dependent serine/threonine protein kinase (DNA-PK) that also includes the DNA-binding protein Ku, composed of two subunits, Ku70 and Ku80 (Blunt et al. 1995; Kirchgessner et al. 1995; Lees-Miller et al. 1995) . Cells lacking either p450 or Ku activity are hypersensitive to DNA damaging agents, suggesting that DNA-PK has an important role in the recognition and repair of DNA damage (for review, see Weaver 1995) . Interestingly, this complex is able to phosphorylate the p53 tumor suppressor protein in vitro, and it has been suggested that such phosphorylation occurs in vivo to stabilize the p53 protein in response to DNA damage (Gottlieb and Jackson 1994) .
Several studies provide evidence that p53 has an important role in protecting cells against DNA damage. The p53 gene is found mutated in many human cancers (Hollstein et al. 1991; Levine et al. 1991) and is required for radiation-induced G1 cell cycle arrest (Kastan et al. 1992) . p53 is also a crucial upstream regulator of apoptosis. Thymocytes and B cells from p53-deficient mice are dramatically resistant to the induction of apoptosis by DNA damage, but retain normal sensitivity to phorbol esters, glucocorticoids, and calcium ionophore (Clarke et al. 1993; Lowe et al. 1993; Strasser et al. 1994b ). Presumably as a consequence of loss of the cell cycle checkpoint regulation and cell death control, p53-deficient mice have a markedly increased susceptibility to developing malignant lymphoma (Donehower et al. 1992; Jacks et al. 1994) .
Because scid lymphocytes have a faulty DNA repair mechanism that results in incomplete V(D)J recombination, we examined whether the scid mutation could cooperate with loss of p53 function to accelerate lymphomagenesis. By intercrossing p53 -/ -mice and scid mice, we found that p53 -/ -scid double mutant animals had a surprising partial rescue of T but not B cell development and, in comparison with control p53-/ -littermates, an accelerated rate of developing lymphoma. We also found that scid cells are able to induce and activate p53-responsive signaling pathways following DNA damage. In summary, our results reveal a role for p53 in a T-cell developmental checkpoint unknown previously and demonstrate for the first time that mutations in independent regulators of the cellular response to DNA damage can cooperate in lymphomagenesis.
Results

p53-/-scid mice show a partial rescue of T-cell, but not B-cell, development
Mice homozygous for the scid mutation are unable to rearrange antigen receptor genes successfully, leading to an arrest in lymphocyte development at the CD4-CD8-CD25 +CD44-pre-T-cell stage and the B220+CD43 + pro-B-cell stage (Bosma et al. 1983; Schuler et al. 1986; Godfrey and Zlotnick 1993) . These animals also have a general defect in DNA damage repair (Fulop and Phillips 1990; Biedermann et al. 1991) . The p53 tumor suppressor has an essential role in the cellular response to DNA damage by inducing either G1 cell cycle arrest, allowing the cell time to repair the damage (Kastan et al. 1992) , or by activating apoptosis to eliminate the damaged cells (Clarke et al. 1993; Lowe et al. 1993) . To examine the combined impact of loss of p53 and defective V(D)J antigen receptor gene recombination on lymphocyte differentiation and neoplastic transformation, we introduced a p53-null allele into scid mice by genetic crosses between the mutant strains. Double mutant p53-/-scid animals were created on two different genetic backgrounds--C.B.-17-C57BL/6-129/Sv and C.B-17-C57BL/6 (see Materials and methods)--and experiments with animals from both cohorts produced similar results.
To investigate the effect of loss of p53 on lymphocyte differentiation in mutant scid mice we isolated thymocytes, bone marrow, spleen, and lymph node cells from 4-to 6-week-old, apparently healthy (not tumor burdened), double mutant p53-~-scid mice, enumerated them, and characterized them by immunofluorescent staining with cell surface marker-specific monoclonal antibodies and flow cytometric analysis.
Thymi from p53 -/ -scid mice contained 2-to 50-fold more lymphocytes than those from control p53 + / + scid and p53 ÷/-scid littermates, although the total number of thymocytes varied greatly between individual animals. As reported previously, p53-/ -mice are indistinguishable from controls with respect to thymus cellularity and subset distribution (Fig. 1A , Table 1 ; Lowe et al. 1993; Strasser et al. 1994bl . Furthermore, as expected, T lymphopoiesis was arrested in p53 + / + scid and p53 +/-scid littermates at the CD4-CD8 -CD25 + CD44-stage ( Fig. 1A ; data not shown). In contrast, p53 -/-scid thymi contained nearly wild-type portions of more mature, CD4-CD8 -CD25 -CD44-and CD4 + CD8 + cells ( Fig. 1A ; data not shown). Recently, Bogue et al. (1996) also observed CD4+CD8 + thymocytes in p53-/-scid mice. The presence of these two differentiation stages was entirely responsible for the increased thymus cellularity and the three earlier thymocyte differentiation stages, CD4 -CD8 -CD25 -CD44 +, CD4 -CD8 -CD25 +CD44 + and CD4-CD8-CD25 +CD44 , were ! present in normal numbers (Table 1 ; data not shown). The p53-/-scid thymocytes were unable to proceed beyond the cortical CD4 + CD8 ÷ stage, because we could not detect any surface expression of TCR~, TCRT~, or CD3~ on double mutant thymocytes or any T cells in peripheral lymphoid organs (data not shown). These data demonstrate that loss of p53 function allows defective scid thymocytes to survive, proliferate, and progress in development beyond the checkpoint that normally requires TCR~ expression.
In contrast to our observations in thymocytes, loss of p53 did not relieve the developmental block in scid B lymphopoiesis. Detailed analysis of bone marrow leukocytes did not identify a difference in number or phenotype among B lineage cells from p53 -/-scid and p53 and SCID in tumorigenesis
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Cold Spring Harbor Laboratory Press on October 24, 2017 -Published by genesdev.cshlp.org Downloaded from from scid mice (for review, see Rolink and Melchers 1991) . Collectively, these data provide evidence for an unsuspected difference in the molecular regulation of early B-and T-cell differentiation, perhaps attributable to the p53-dependent elimination of defective lymphoid progenitors that may occur in the T-cell, but not the B-cell, lineage.
CD4 + CD8 + thymocytes in p53 -/-scid rnice are polyclonal
The observation that the double mutant animals had significantly increased thymus cellularity consisting predominantly of CD4 +CD8 + cells suggested that loss of p53 allowed immature thymocytes to progress further in development despite the absence of TCR~. However, it was also possible that the increased cellularity resulted from a clonal expansion of one or a few transformed cells. To examine this question further, we characterized the diversity of the coding joints of a TCR gene segment from DNA isolated from populations of double mutant thymocytes. Coding joints form inefficiently in scid thymocytes, and the rearrangements that have been characterized usually contain gross deletions at the joints (Lieberet al. 1988) . DNA was extracted from thymi of fiveto six-week-old p53-/-scid mice, and the TCR D~-J~ joints were amplified by PCR using primers that recognize the 5' end of the Dp region and the 3' end of the J~l.2 segment. DNA from p53-/ -scid mice yielded predominantly the unrearranged germ-line band of -1.2 kb and two faint bands of 350 and 500 bp, corresponding to rare rearrangements to the J~l.2 and J~l.1 segments, respectively (data not shown). The band corresponding to the J~l.1 rearrangement was purified, reamplified by PCR, and subcloned to create a library of TCRp joints. These clones were sequenced and compared with published TCR~-region sequences to determine the nature of the joints (Table 2 ). This analysis revealed that p53-/-scid thymocytes contained a variety of largely nonproductive rearrangements, indicating that these cells were polyclonal. It is noteworthy that most of the joints from p53-/-scid mice, unlike those in scid thymocytes, did not show significant deletions at the coding ends. These data indicate that the absence of p53 allows a polyclonal population of defective scid thymocytes to 
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Sequence analysis of coding joints in thymocytes from p53 -/-scid mice shows a diversity of TCR~ gene rearrangements. Dpl-J~l. 1 coding joints from thymocytes of one WT mouse and two p53-/-scid mice was amplified by PCR and subcloned into the pT7blue vector. Three individual WT clones were analyzed and the sequences are shown {W1, W2, and W5). A total of 15 clones from the two double mutant animals were sequenced. Only two of the fifteen clones showed the same sequence at the joint (D32-4 and D32-8). Elimination of p53 function in the scid mutant resulted in the development of lymphoma with strikingly early onset. Lymphoma presenting in lymph nodes, spleen, bone marrow, and/or thymus was apparent in >70% of the C57BL/6-129/Sv-C.B-17 double mutant mice that had to be sacrificed because of poor health (n = 42). In the C57BL/6-129/Sv-C.B-17 cohort, p53 -/-scid mice with lymphoma were sacrificed on average at 10 weeks, compared with the p53-/-scid + / -mice that had to be sacrificed because of lymphoma at a mean age of 18 weeks ( Fig. 2A) . Similarly, the C57BL/6-C.B-17 p53 -/-scid mice that developed lymphoma (n = 19) were sacrificed Age (days) Figure 2. p53-/-scid mice develop lymphoma earlier than p53 -/-mice. (A) C57BL/6-129/Sv-C.B-17 double mutant mice (n = 42) were sacrificed or died because of lymphoma between 42-105 days of age (G), whereas C57BL/6-129/Sv-C.B-17 p53-/ -scid + / -mice (n = 13) were sacrificed or died because of lymphoma between 77 and 171 days of age (1). {B) C57BL/ 6-C.B-17 double mutant mice In = 19) were sacrificed or died because of thymic lymphoma at 50-200 days of age (A). C57BL/ 6-C.B-17 p53 -/-scid +/-mice (n = 24)were sacrificed or died because of lymphoma at 75-300 days of age (11).
on average at 14 weeks, whereas the p53 -/-controls with lymphoma were sacrificed on average at 19 weeks (Fig. 2B ). Only one out of nine p53 +/+ scid mice (11%) developed lymphoma by 30 weeks (data not shown), consistent with previous reports (Bosma and Carroll 1991) . Homozygous mutation of the scid locus also accelerated lymphomagenesis in p53 + / -heterozygous mice; in both cohorts 30%-40% of p53 +/-scid mice had developed lymphoma by 27 weeks compared with K5% in control p53 ~-/ -mice ; data not shown). In summary, these results demonstrate that loss of p53 and a defect in DNA repair can cooperate in lymphomagenesis.
p53--/-scid mice develop T-and B-cell lymphoma
Immunofluorescence staining and flow cytometric analysis of tumor cells from lymph nodes of moribund double mutant animals revealed that some were of T-cell and others of B-cell origin (Fig. 3) . The T-cell tumors were CD4+CD8+B220 -( Fig. 3c ; Table 3 )and the B-cell tumors were CD4-CD8-B220 + ( Fig. 3d ; Table 3 ). All of the B-cell tumors from double mutant mice lacked surface IgM (Fig. 3d) and TCR~, TCR~, CD3~ (not shown), as expected given the scid mutant background. Table 3 shows a more detailed characterization of five double mutant lymphoma cell lines derived from tumors that had presented in both the thymus and the lymph nodes. The presence of CD19, CD22, B220, and class II major histocompatiblity complex (MHC), and the absence of CD21 and CD23 on the cell surface indicated that the B-cell lymphomas had originated from pre-B cells.
Immunohistochemical analysis using an antibody that recognizes B220 was consistent with the FACScan analysis data. All of the eight thymic lymphomas analyzed from the double mutant animals stained for B220 (data not shown). Interestingly, approximately one-third of the tumors analyzed had patches of B220 + tumor cells and patches of B220-tumor cells, whereas two-thirds was uniformly B220 +. Southern blot analyses of DNA from these tumors revealed that those showing incomplete B220 staining had undergone both TCR D~I rearrangements and Ig D H rearrangements, indicating that some of the tumors consisted of a mixture of T and B cells (data not shown). However, FACScan analysis of tumor cells from the lymph node of double mutant animals detected either T-cell or B-cell tumors, but not tumors of mixed cell type (Fig. 3) . It is noteworthy that previous analysis of thymic lymphomas from C57BL/6-129/Sv p53 -/-mice showed that nearly all were CD4+CD8 + T. Jacks, A. Strasser, and A.W. Harris, unpubl.) . However, in the C57BL/6--C.B-17 genetic background, 2 of 15 lymphomas analyzed were of B lineage origin ( Fig.  3 ; data not shown).
scid cells induce p53 protein expressio~ and arrest in G1 following ionizing radiation
It has been suggested that the DNA-PK complex that includes the protein encoded by the scid locus is re- quired to activate p53 in response to D N A damage (Gottlieb and Jackson 1994) . However, the data described above show that the scid and p53 mutations can cooperate in lymphomagenesis and that loss of p53 in a scid m u t a n t background results in partial rescue of thymocyte development, suggesting that these gene products might be able to act independently in the cellular response to D N A damage. To examine directly if the scid locus encoded protein, D N A protein kinase (DNA-PKcs), is required to induce or activate p53 in response to D N A damage, we tested whether mutant scid cells could respond to ionizing radiation by inducing p53 protein expression and arresting in the G1 phase of the cell cycle.
Wild-type, p53 -/ -, and scid thymocytes were exposed to 6 Gy of ionizing radiation, and cell lysates were made 4 hr following treatment. As shown in Figure 4 , immunoblot analysis demonstrated that following D N A damage the p53 protein concentration is increased in scid thymocytes to levels comparable with those seen in normal cells. Furthermore, untreated scid thymocytes had higher levels of p53 protein than untreated wild-type thymocytes, suggesting that in scid thymocytes with defective DNA, p53 may be induced constitutively ( Fig. 4 ; see below).
Mouse embryo fibroblasts (MEFs) derived from 13.5-day-old embryos were used to determine whether the p53-mediated G 1-arrest response following D N A damage was active in scid cells (Fig. 5) . Wild-type, p 5 3 -/ -, and three different scid fibroblast lines were exposed to 6 Gy of ionizing radiation and incubated at 37°C for 12 hr before pulse-labeling with the thymidine analogue BrdU for 4 hr (described in Kastan et al. 1991) . The cells were fixed and stained with the D N A intercalating dye propidium iodide and a fluorescent anti-BrdU antibody and analyzed by flow cytometry (Fig. 5A ). This experiment revealed that following irradiation, scict fibroblasts arrested in G] to the same extent as wild-type fibroblasts, as indicated by an absence of cells entering S phase (Fig.  5B) . As reported previously, p 5 3 -/ -cells did not arrest efficiently in G~ (Kastan et al. 1992 ). Interestingly, although the G~ arrest in scid fibroblasts was similar to that in wild-type cells, the G2 arrest was more pronounced in scid cells. This result is consistent with earlier studies (Weibezahn et al. 1985) and suggests a possible role for DNA-PKcs in regulating the exit from G2 arrest following D N A damage.
There have been several recent reports that p53 has a role in the G2/M arrest following D N A damage (Guillouf et al. 1995; Agarwal et al. 1995; Powell et al. 1995) . To determine if the more pronounced G~ arrest associated with the scicl mutation is dependent on p53, we performed the BrdU-labeling experiment described above on fibroblasts derived from p 5 3 -/ -scid mice. Figure 5 , C and D, shows that p53 -/ -scid cells, as expected, did not arrest efficiently in G 1 following exposure to ionizing radiation, but were able to arrest in G 2 to the same extent as scid cells. Therefore, p53 function is not required for the G~ arrest seen after irradiation of scid fibroblasts.
scid thymocytes undergo apoptosis in response to DNA damage
The e x p e r i m e n t s described above show that DNA-PKcs is not required to induce p53 protein expression or activate p53 for its role in cell cycle arrest. To examine if DNA-PKcs is required to activate p53-dependent apoptosis, we compared the ability of irradiated scid thymocytes to undergo programmed cell death w i t h that of irradiated wild-type t h y m o c y t e s . I m m a t u r e CD4 -CD8 -C D 3 -C D 2 5 + C D 4 4 -(DN) were isolated from normal (Balb/c), scid, and p53 -/ -mice (see Materials and methods) and either left untreated or 7-irradiated w i t h 250, 500, 750, or 1000 rads. Viability was determined for up to 48 hr following treatment. Figure 6B shows the viability of t h y m o c y t e s of each genotype at 6 hr following treatment. Both scid and n o r m a l D N t h y m o c y t e s died efficiently after exposure to 250 rads, whereas p 5 3 -/ -D N t h y m o c y t e s were h i g h l y resistant to radiation-induced death, even up to 1000 rads. However, p53 -/ -thymocytes died by 48 hr following exposure to 250 rads (Fig.   6C ). U n t r e a t e d t h y m o c y t e s from scid mice were also highly susceptible to death in tissue culture (Fig. 6A) , suggesting that these cells m a y be fragile because of their intrinsic D N A damage. In sum, these data demonstrate that the scid gene product, DNA-PKcs, is not required to induce or activate the p53 protein in response to D N A damage. Together, these data strongly suggest that the two genes f u n c t i o n in distinct D N A damage control pathways.
Discussion
A l t h o u g h it is k n o w n that p53 induces cell cycle arrest or apoptosis in response to ionizing radiation, the signals that activate p53 and the m e c h a n i s m of the cellular response to increased levels of p53 are still largely unknown. We and others have s h o w n that t r e a t m e n t w i t h agents that induce double-strand D N A breaks results in the i n d u c t i o n a n d / o r activation of p53 (Clarke et al. 1993; Lowe et al. 1993; Ziegler et al. 1994) , suggesting that it is the broken D N A ends that act as an activation counted for by an increase in the CD4 +CD8 + population. Sequence analysis of the TCR D~-J~ joints demonstrated that the double m u t a n t thymocytes were polyclonal and therefore resulted from developmental rescue rather than from the outgrowth of a single transformed clone. These data suggest that the unjoined DNA ends in scid thymocytes activate one or several p53-dependent pathways to induce growth arrest and/or apoptosis that results in the elimination of a large percentage of these defective cells. It is unclear whether it is the loss of p53-dependent cell cycle arrest, apoptosis, or a combination of both that produces this phenotype in p 5 3 -/ -scid thymocytes. Overexpression of the physiological cell death inhibitor Bcl-2 antagonizes p53-mediated apoptosis in all cell types tested so far (Wang et al. 1993; Chiou et al. 1994; Strasser et al. 1994b ) but has no detectable influence on in vivo survival and differentiation of scid T cells. It is therefore possible that loss of function of the p53-dependent apoptotic pathway is insufficient to promote expansion and differentiation of scid thymocytes. However, Bcl-2 can inhibit p53-dependent apoptosis by inducing cell cycle arrest (Chiou et al. 1994 ) and this may explain why Bcl-2 is unable to rescue T-ceU development in scid m u t a n t mice. The data are also consistent with a requirement for p53-mediated cell cycle arrest as a constituent of the checkpoint in T lymphopoiesis that selects for productive TCR~ rearrangement. It is interesting to note that this checkpoint is preceded by Hour Post Irradiation Figure 6 . The scid mutation does not interfere with p53-dependent apoptosis in thymocytes. Survival of CD3 CD4-CD8-CD25 ÷CD44 thymocytes (A) in tissue culture without radiation treatment; (B) 6 hr following treatment with 250--1000 rads (100 rads = 1 Gy); (C) up to 48 hr following treatment with 250 rads. scid (O} and wild-type ( • ) thymocytes are highly radiosensitive, whereas p53-/-{'1 thymocytes are resistant.
the influence of a signal that requires TCR~, gp33, and the CD3 complex (Mombaerts et al. 1992; Godfrey and Zlotnick 1993; Godfrey et al. 1994; Fehling et al. 1995) . Consistent with the idea that activation of this immature TCR complex generates a signal that promotes cellular proliferation and development is the discovery that injection of agonistic antibodies to CD3 or TCR~ into mutant scid or rag-l-deficient mice leads to a dramatic increase in thymocyte number and promotes their differentiation to CD4+CD8 + stage (Shinkai et al. 1992; Levelt et al. 1993; Guidos et al. 1995) . Interestingly, ionizing radiation itself can trigger a signal that promotes in vivo proliferation and differentiation of scid mutant thymocytes arrested at the CD4-CD8-CD25 +CD44-stage (Danska et al. 1994; Zufdga-Pflucker et al. 1994) , perhaps by activating an alternative DNA damage repair pathway. In contrast to the data from T-lineage cells, we did not observe rescue of B-cell development in p53 -/-scid mice, suggesting that p53 is not essential for the checkpoint that selects for productive rearrangement of the IgH locus. The notion of differences in the molecular regulation of these corresponding checkpoints between B and T cells is supported by the observations that radiation treatment rescues T-, but not B-, cell development in scicl mice (Danska et al. 1994; Zufdga-Pflucker et al. 1994) , whereas BcI-2 overexpression promotes B-, but not T-, cell development in scid lymphocytes (Strasser et al. 1994a) .
The data described above coupled with the high incidence of thymic lymphoma in p53-/ -mice (Donehower et al. 1992 ) support a model in which a p53-dependent pathway leads to the elimination of cells with faulty or incomplete antigen receptor gene rearrangements that could produce oncogenic mutations by either activating proto-oncogenes or inactivating tumor supressor genes. This model predicts that p53 -/-scid lymphocytes should be markedly predisposed to neoplastic transformation. Our data show that p53 -j-scid animals develop lymphoma with an earlier onset than genetic background-matched p53 -/-animals. However, the observed phenotype may also reflect the cooperation between a general defect in DNA repair and the absence of p53.
Although most of the tumors presented in the thymus and in other lymphoid organs, further characterization revealed unexpectedly that the majority (60-70%) of the p53-/-scid lymphomas were of pre-B-cell origin, and the rest of pre-T-cell origin ( Fig. 3; Table 3 ). What might be the explanation for this surprising preponderance of pre-B lymphomas, given that only the T-, but not the B-, cell lineage was affected noticeably in healthy double mutant animals (see Fig. 1B )? Genetic background may influence the type of lymphoma that is elicited by a particular mutation. Lymphomas in p53-j -C57BL/6-129/ Sv mice are predominantly, if not exclusively, of CD4+CD8 + T-cell origin , whereas 13% of p53 -/ -C.B-17-C5 7BL/6 mice developed B-cell lymphoma (e.g., see Fig. 3 ). Similarly, expression of a v-abt transgene elicits predominantly CD4 + CD8 + thymomas on a C57BL/6 background but mostly pre-B lymphomas on a BALB/c background (Harris 1991) . The stochastic onset of tumors in these double mutant animals suggests that one or several additional, oncogenic mutations are required for malignant transformation. Another explanation for the preponderance of pre-B over pre-T lymphomas in p53-/-scid mice is the possibility that cooperating oncogenes are activated more easily in B cells, perhaps because they are situated in the vicinity of the IgH or IgL loci and, therefore, are at increased risk of mutagenesis. Moreover, the block in B-cell differentiation at a stage characterized by high turnover could contribute to their neoplastic transformation, whereas, in contrast, pre-malignant p53-/-scid T cells can differentiate into short-lived postmitotic cortical CD4 + CD8 + cells that may be at lower risk of sustaining further mutations. It will be interesting to define in further in vivo and in vitro experiments which oncogenes are able to synergize with the p53 and scicl mutations in lymphomagenesis.
The kinase complex that contains the scid locus encoded protein DNA-PKcs phosphorylates p53 in vitro, and it has been suggested that such phosphorylation occurs in vivo to induce or activate the p53 protein for its role in the cellular response to DNA damage (Gottlieb and Jackson 1994) . Our data on lymphoma onset in double mutant mice indicate that the p53 and scid mutations cooperate in tumorigenesis, suggesting that they may function in distinct double-strand DNA damage response pathways. We demonstrated directly that the scid gene product is not required to induce or activate p53 in response to DNA damage by showing that radiation-induced p53-responsive pathways are active in scid cells. Mutant scid thymocytes were able to induce p53 protein expression following ~/-radiation and the p53-mediated G 1 arrest in fibroblasts was functional in scid fibroblasts. Furthermore, p53-dependent apoptosis occurred in scid DN thymocytes exposed to ionizing radiation, even at very low doses of radiation. It is interesting to speculate that the extreme sensitivity of scid thymocytes to radiation is attributable to a primed p53 DNA damage response pathway caused by the endogenous damaged DNA in these cells. All of these data argue strongly that p53 and DNA-PKcs are in different DNA damage repair pathways. Our results are consistent with a recent report showing that p53 is required for radiation-induced rescue of V(D)J recombination in scid thymocytes (Bogue et al. 1996) , perhaps because radiation activates a p53-dependent DNA damage repair pathway that allows V(D)I rearrangement to proceed.
The function of p53 in the DNA damage response is clearly crucial to the proper functioning of many cell types. Humans afflicted with Li-Fraumeni syndrome or ataxia-telangiectasia lack normal p53 function and are highly predisposed to developing tumors, including lymphoma (Morrell et al. 1986; Hecht and Hecht 1990; Malkin 1993 ). Moreover, a p53 mutation dramatically sensitizes mice to radiation; irradiated p53-heterozygotes develop tumors, particularly lymphoma, with a reduced latency (Kemp et al. 1994} . Our data suggest a role for p53 in sensing double-strand DNA ends caused, not only by exogenously introduced damaging agents such as radiation, but also by faulty antigen receptor gene rearrangement. Specifically, the loss of p53 leads to the survival of defective pre-T lymphocytes and can cooperate with mutations that affect antigen receptor gene rearrangement in lymphomagenesis. Further studies on the combinatorial effects of p53 mutations associated with other mutations that affect DNA recombination and/or repair are therefore expected to increase our understanding of the physiological role of p53 in the cellular response to DNA damage and the checkpoint controls during lymphopoiesis.
Materials and methods
Generation of p53-/ scid mice
Homozygous mutant p53-/-mice (C57BL/6--129/Sv) were bred with homozygous mutant C.B-17 scid mice from Taconic Laboratories (Germantown, NY) or the Walter and Eliza Hall Institute of Medical Research animal breeding facilities (Kew, Australia) to obtain F 1 p53 +/-scid +/-offspring. Double mutant animals were then generated by two possible breeding protocols: F~ p53 +/-scid +/-animals were backcrossed to scid mice to fix the scid mutation and double mutant mice were created by intercrossing the p53 +/-scid F 2 animals. These were the mice on the C57BL/6-129/Sv-C.B-17 background. Alternatively p53-/-scid mice were generated by cross-breeding F~ animals; these were the mice on the C57BL/ 6-C.B-17 background. Homozygosity for the scid mutation was confirmed by FACS analysis of peripheral blood lymphocytes with antibodies against B220 and CD3e, as described below, p53 status was determined by PCR analysis of tail or peripheral blood leukocyte DNA as described previously ). All crosses were carried out under specific pathogen free (SPF) conditions. Mice were placed on a sulfamethoxazole regimen to control Pneumocysitis cariniJ infection.
Flow cytometry
Flow cytometric analysis was performed using a FACScan (Becton Dickinson). FITC-or phycoerythrin-conjugated monoclonal antibodies directed against CD4, CD8, TCRa~, TCR~, B220, and IgM, were obtained from Pharmingen. All other antibodies were prepared and used as described previously (Strasser et al. 1991) . Monoclonal antibodies were labeled either with fluorescein isothiocyanate (FITC) or biotin and revealed with R-phycoerythrin (R-PE) streptavidin (Caltag).
Cell cycle analysis was performed using methods described previously (Kastan et al. 1991) . Briefly, MEFs were derived from 13.5-day-old embryos and exposed to 0 or 6 Gy of ionizing radiation. The cells were incubated at 37°C for 12 hr, then labeled with bromodeoxyuridine (BrdU) for 4 hr at 37°C. Cells were harvested, fixed, and stained with propidium iodide and a FITCconjugated anti-BrdU antibody (Boehringer Mannheim).
Sequence analysis of D~-I~ joints
DNA was extracted from the thymi of 5-to 6-week old C57BL/ 6-129/Sv-C.B-17 p53-/-scid mice. TCR D~-J, joints were amplified by PCR using the following primers: (D~) 5'-TTTTG- [J~,.2 )5'-AGTCCCAGACATGAGAGAGC-3'. The 500-bp band corresponding to the D~-J~l.l was purified, reamplified by PCR, and subcloned into the pT7blue vector (Novagen). DNA was extracted from individual colonies and sequenced using either the DI~ primer or the universal U19 primer.
TA(T/C)(C/A}A(T/A)G(G/CITGTAACATTGTG-3',
Tumor analysis
Animals that died or were sacrificed were subjected to necropsy. Tumor samples were removed and fixed in 10% neutral buffered formalin. Specimens were processed for histology, embedded in paraffin, sectioned at 6 ~ and stained with hematoxylin and eosin.
Immunoblot analysis
Thymocytes from wild-type, p53-/-, and scid mice were exposed to 0 or 6 Gy of ionizing radiation from a 137 Cesium source. Four hours following treatment, cells were resuspended in RIPA buffer (300 mM NaC1, 50 mM Tris at pH 7.2, 1% sodum deoxycholate, 1% Triton X-100, 0.1% SDS, 1 mM sodium pyro-phosphate, 1 mM DTT, 1 ~g/ml of aprotinin, 0.5 mM benzamidine, 1 ~,g/ml of pepstatin, and 0.5 mM PMSF), and pulse-sonicated. Extracts were incubated with 50 units of DNase I on ice for 30 min and cleared by centrifugation for 30 min. Proteins were electrophoretically separated on a 12% SDS-PA gel and transferred to polyvinylidene difluoride {PVDF) (Westran; Schleicher & Schuell]. Protein was detected by incubation with an antibody that recognizes p53 (Ab-3; Oncogene Science), followed by incubation with chemiluminescent reagents (ECL, Amersham).
Cell sorting and cell death analysis
Cells were purified essentially as described by staining isolated thymocytes with rat monoclonal antibodies to CD3, CD4, CD8, B220, Gr-1, Mac-l, and Terll9. Cells were then incubated with goat anti-rat immunoglobulin magnetic beads to deplete bound cells. The remainder were stained with Tricolor goat anti-rat immunoglobulin (Caltag) to stain the unwanted cells that were not depleted by the magnet. Next, the cells were stained with anti-CD25-PE (Caltag), biotinylated anti-CD44, and Texas red anti-Thy-I in the presence of 1% rat serum to prevent binding of the Tricolor anti-rat antibodies to rat anti-CD25, -CD44, or -Thy-1. Finally, the cells were stained with streptavidin-FITC (Caltag), in the presence of 1% rat serum, to reveal the biotinylated anti-CD44 antibody. Using the FACSstar Plus or a modified FACSII, 2x105 cells from each mouse were sorted. Cells were then resuspended in Dulbecco's modified Eagle medium {DMEM) supplemented with 10% FCS, 50 ~M 2-ME, 13 mM folic acid, and 250 mM L-Asn at a densitiy of 2x l0 s cells/ml. Cells were left untreated or exposed to 250, 500, 750, or 1000 rads of ionizing radiation from a ~37Cesium source. Viability was determined after 6, 18, 24, and 48 hr by visual inspection using phase-contrast on an inverted microscope.
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